missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30171971

Integrin alpha V/CD51 Antibody (abituzumab) [Janelia Fluor™ 525], Novus Biologicals™

Human Monoclonal Antibody

Brand:  Novus Biologicals (Bio-Techne) NBP3-28527JF525

3217.25 NOK valid until 2025-12-16
Use promo code "24090" to get your promotional price.

Product Code. 30171971

  • 3790.00 NOK / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Integrin alpha V/CD51 Monoclonal antibody specifically detects Integrin alpha V/CD51 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Integrin alpha V/CD51
Monoclonal
Janelia Fluor 525
antigen identified by monoclonal L230, CD51, CD51 antigen, integrin alpha-V, integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51), MSK8, Vitronectin receptor subunit alpha, VNRADKFZp686A08142
Integrin aV/ ITGAV/ CD51
0.1 mL
Adaptive Immunity, Angiogenesis, Cancer, Cell Biology, Cellular Markers, Immunology, Signal Transduction
3685
Store at 4°C in the dark.
IgG2
Flow Cytometry, ELISA, Functional Assay
abituzumab
50mM Sodium Borate
Human
Protein A purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.